A pilot study of the efficacy of CAR T-cell therapy in patients with EGFRvIII-positive glioblastoma multiforme (GBM) has generated encouraging findings.
Lauren M. Green
Advertisement
Articles by Lauren M. Green
Advertisement
Latest Updated Articles
Early Research Signals Potential for CAR T-Cell Therapy in EGFRvIII-Positive GBMPublished: November 22nd 2015 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
2
Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings
3
Key Unknowns Remain in Cell and Gene Therapy
4
ImmunoLogic, Episode 7: "Turbocharging CAR T-Cells: The IL-9 Orthogonal Signal" With Anusha Kalbasi, MD
5
